Viruses aren't just disease agents any more. Scientists now know they can be used in therapies for cancer but concerns over the safety of 'oncolytic viruses' remain because they can also damage healthy tissues.
But Mayo Clinic researchers say they have discovered a way of controlling the viruses behind potential cancer therapeutics by engineering the virus's genetic sequence, using microRNAs to restrict them to specific tissues. The microRNAs destabilize the virus's genome, making it impossible for the virus to run amok. The discovery is reported in the current issue of Nature Medicine.
MicroRNAs are the nucleotide snippets that are encoded by genes, but don't end up as proteins. In many cases, they have a role in down-regulating different cellular genes. In this case, a virus is engineered to be responsive to microRNAs that are present in certain cell types. Using this new form of targeting, researchers redirected a virus normally responsible for a lethal muscle infection to recognize only cancer cells. The laboratory mice that received the engineered virus were cured of established tumors and suffered no ill effects.
"Our findings demonstrate a new tool for molecular medicine that should also help allay concern over the use of viruses as a therapeutic delivery system," says Stephen Russell, M.D., Ph.D., Mayo physician-scientist and lead author of the study.
Significance of the research
Most viruses can infect different cell types, which leads to the array of symptoms during a viral infection. Now as viruses are being engineered for use as vaccines, cancer therapeutics and gene therapy vectors, researchers want to restrict and redirect the types of cells they do (or don't) infect as additional safeguards against disease. The target sequences of microRNAs used in the study kept the virus from destroying muscle cells while allowing viral replication to proceed in cancer cells allowing the virus to completely cure mice with melanoma.
The Mayo researchers say microRNA target insertion may be a new way to make viruses safer for use in cancer therapy and could lead to new methods of making safer vaccines.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Crossref To Accept Preprints In Change To Long-standing Policy
- A Statistics Session At A Particle Physics Conference ?
- The Venus Flytrap: From Prey To Predator
- Beekeepers Can Be Hazardous To Bees
- The Number Of My Publications Has Four Digits
- 'Super Males' Emerge From Male-dominated Populations, Study Finds
- Wildlife Loss In Tropical Forests Is Bad News For Everyone
- "Right - the chances that I know more about that than the examiner are very high anyway :)In any..."
- "So is this thing real then or not read somewhere saying it will hit around September this year..."
- "This is NOT my goal. ... My goal is ... a number that can be added, subtracted, multiplied, and..."
- "Is anyone aware that you have to have 80% villous (spelling?) atrophy to get a celiac diagnosis..."
- "Hello MathGeek:Thank you for stating your starting position so clearly:This is NOT my goal. I also..."
- Continental drift created biologically diverse coral reefs
- Silk keeps fruit fresh without refrigeration, according to Tufts study
- Temple study examines whether compression stockings can prevent post-thrombotic syndrome
- Research collaboration IDs serum biomarkers that predict preclinical IBD development and complications
- 'Super males' emerge from male-dominated populations, study finds